Data Supplement from PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13-cis Retinoic Acid–Mediated Differentiation in Neuroblastoma
Year: 2023
Type: other
Abstract: Supplementary Figure 4: A) expression of PBX1 in high-risk tumors from 6A; B)EFS of patient set of 6B; C)Subset analysis of patient set in 6C, <18 months of age; D)Subset analysis of patient set in 6C, MYCN-nonamplified tumors.
Authors: Nilay Shah, Jianjun Wang, Julia Selich-Anderson, Garrett Graham, Hasan Siddiqui, Xin Li, Javed Khan, Jeffrey Toretsky
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362433566